Rockefeller Capital Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
ACM
WHG
Rockefeller Capital Management's BSX.PRA Position: Q2 2022 in Review
Rockefeller Capital Management sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2022, closing a stake of 41 shares — an estimated $4K sold.
Rockefeller Capital Management first reported a position in BSX.PRA in Q4 2021 and held it in 2 quarters. The position peaked at $4K in Q1 2022. 52 funds tracked by Wall St. Rank hold BSX.PRA as of Q2 2022.
- Rockefeller Capital Management reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2022 after selling out during the quarter.
- Rockefeller Capital Management sold 41 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2022, an estimated $4K.
- Rockefeller Capital Management first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2021 and held it in 2 quarters.
- Rockefeller Capital Management's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $4K in Q1 2022.
- 52 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2022.
Based on Rockefeller Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.